Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Insilicogen
Yongin-si, South Korea
A
11-50 Employees
2005
Key takeaway
Insilicogen has built a robust bio big data infrastructure over the past 20 years, positioning itself as a leader in data production, archiving, modeling, and analysis, which are crucial processes in RNA sequencing.
Reference
Product
Solution | Insilicogen, Inc.
New Era for Bioinformatics
BIORCHESTRA
Chungju-si, South Korea
A
1-10 Employees
2016
Key takeaway
At BIORCHESTRA, the focus is on developing innovative RNA medicines and delivery systems that address critical medical needs in neurodegenerative and rare diseases of the Central Nervous System. Their advanced technology enhances the encapsulation and targeted delivery of RNA therapeutics to brain cells, highlighting their commitment to transforming patient care through RNA-based solutions.
Reference
Core business
BIORCHESTRA – Innovative RNA Therapeutics
GENECAST
Seoul, South Korea
A
11-50 Employees
2016
Key takeaway
GENECAST is a company that specializes in liquid biopsy for early cancer detection, highlighting their innovative ADPS™ technology which offers exceptional sensitivity. This advanced detection capability enhances cancer management and treatment options.
Reference
Core business
Liquid Biopsy for Cancer Diagnosis - GENECAST
GENECAST specializes in Liquid Biopsy for early detection in Cancer Diagnosis. We have developed ADPS™, a Technology with 0.001% sensitivity ✓ Contact Us.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Koram Biotech & Koram Biogen Corp
Seoul, South Korea
A
51-100 Employees
1988
Key takeaway
The company, NEB (New England Biolabs), offers GMP-grade products that adhere to ISO 9001 & ISO 13485:2016 quality management standards, ensuring high lot-to-lot consistency through qualified equipment and controlled manufacturing processes.
Reference
Product
ATCC
Spidercore Inc.
Daejeon, South Korea
A
1-10 Employees
2020
Key takeaway
Spidercore's S.Core platform utilizes a hyper-scale AI engine to analyze nucleotides, supporting the discovery of gene therapies. Their focus on AI-driven biomedical solutions enhances decision-making in gene-based therapies, which is a key area in modern medicine.
Reference
Core business
Spidercore Inc.
MxT Biotech
Seoul, South Korea
A
1-10 Employees
2021
Key takeaway
MxT Biotech is advancing cancer immunotherapy, cellular engineering, and genome editing through its innovative Hydroporator® platform, which enables the efficient delivery of mRNA and other genetic materials into primary cells.
Reference
Core business
MxT Biotech :: Microfluidics x Therapy
We transform cancer immunotherapy, cellular engineering and genome editing with our patented non-viral genome editing technology, Hydroporator .
RheoMeditech Inc.
Seoul, South Korea
A
1-10 Employees
2003
Key takeaway
The company, RheoMeditech, specializes in advanced diagnostic technologies, including the Anysis system, which rapidly evaluates platelet function and anti-platelet drug response. Their innovative approach, utilizing laser-optics and microfluidics, ensures quick and precise results, contributing to effective patient management in thrombosis and related conditions.
Reference
Core business
Anysis | Rheomeditech Inc. | Seoul
Platelet Function Test in less than 4 minutes, Early diagnosis of Diabetic complications in a minute - RheoSCAN, ESR (erythrocyte sedimentation rate) in 20 seconds - RheoESR. The platelet function test analyzer(ANYSIS) is automated instrument used globally to test 5 different assays in one device. Visit our website for more information.
GC Genome
Yongin-si, South Korea
A
251-500 Employees
2013
Key takeaway
GC Genome Corporation offers a comprehensive portfolio that includes solutions for clinical genetic testing and precision oncology, which may be relevant for applications in RNA sequencing.
Reference
Core business
GC Genome | Clinical Genetic Testing | South Korea
GC Genome | Clinical Genetic Testing | NIPT | Newborn Screening | Cancer Panel | Precision Oncology | Health Checkup
Onegene Biotechnology
Seongnam-si, South Korea
A
- Employees
2016
Key takeaway
Onegene Biotechnology is focused on advancing research and development in multi-target drug development, which may involve innovative approaches like RNA sequencing. Their expertise in dissecting disease microenvironments and developing multi-specific drugs positions them at the forefront of tackling complex diseases.
Reference
Core business
ONEGENE BIOTECHNOLOGY
N-BIOTEK
Bucheon-si, South Korea
A
51-100 Employees
-
Key takeaway
N-BIOTEK specializes in providing comprehensive solutions for stem cell research and regenerative medicine, which may involve advanced techniques like RNA sequencing. Their expertise in life science equipment and stem cell culture technology positions them as a key player in the field.
Reference
Product
Stem Cell Isolation Package - Lab Equipment - N-BIOTEK
N-BIOTEK
Technologies which have been searched by others and may be interesting for you:
When exploring the RNA Sequencing industry in South Korea, several key considerations should be taken into account. The country boasts a robust biotechnology sector, supported by significant government investment and a strong emphasis on research and development. Regulations governing genetic research are stringent, necessitating compliance with ethical standards and safety protocols. It's crucial to understand the challenges posed by competition, as South Korea is home to numerous domestic and international players in the biotech field. Opportunities abound, particularly in personalized medicine and diagnostics, driven by the increasing demand for advanced genomic technologies. Furthermore, the global market relevance of RNA sequencing continues to expand, fueled by trends in precision medicine and drug discovery. Environmental concerns related to laboratory waste and biohazard management also play a role in operational practices. Networking within industry conferences and collaborations with research institutions can provide valuable insights and foster partnerships. Additionally, staying informed about advancements in sequencing technology and bioinformatics tools will be essential for navigating this dynamic landscape. Overall, a deep understanding of the regulatory environment, market trends, and competitive dynamics will be vital for success in South Korea's RNA sequencing industry.
Some interesting numbers and facts about your company results for RNA Sequencing
| Country with most fitting companies | South Korea |
| Amount of fitting manufacturers | 14 |
| Amount of suitable service providers | 3 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1988 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for RNA Sequencing
What are related technologies to RNA Sequencing?
Based on our calculations related technologies to RNA Sequencing are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of RNA Sequencing?
Start-Ups who are working in RNA Sequencing are MxT Biotech
Which industries are mostly working on RNA Sequencing?
The most represented industries which are working in RNA Sequencing are Biotechnology, IT, Software and Services, Medical, Other, Pharmaceuticals
How does ensun find these RNA Sequencing Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.